FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

C3C AND C4 RID KITS

K Number: K902382 · Decision Sep 7, 1990
Classifications
1
FEI Numbers
32
Registration Numbers
32
Same Product Code
43
Applicant Total
115
Review Days
100

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
C3C AND C4 RID KITS
K Number
K902382
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.5240
Medical Specialty
Immunology
Decision
Substantially Equivalent
Applicant
The Binding Site, Ltd.
Date Received
May 30, 1990
Decision Date
September 7, 1990
Product Code
CZW
Advisory Committee
Immunology
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
CZW Complement C3, Antigen, Antiserum, Control

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (CZW), ordered by most recent decision date.

View all

Other Clearances by The Binding Site, Ltd.

K Number Device Name
K231290 Optilite® Freelite® Kappa Free Kit, Optilite® Freelite® Lambda Free Kit
K090920 HUMAN IGG SUBCLASS LIQUID REAGENT KITS (FOR USE ON HITACHI 911/ 912/ 917 AND MODULAR P)
K083289 HUMAN BETA-2 MICROGLOBULIN KIT
K082129 HUMAN IGM LIQUID REAGENT KIT FOR USE ON THE SPAPLUS ANALYZER
K081827 HUMAN IGA LIQUID REAGENT KIT FOR USE ON SPAPLUS
K081674 BINDAZYME HUMAN ANTI-GLIADIN (MGP), IGG EIA KIT; BINDAZYME HUMAN ANTI-GLIADIN (MGP) IGA EIA KIT; (IGA OR IGG)
K080384 HUMAN CYSTATIN C KIT FOR USE ON MODULAR P ANALYSER
K072889 HUMAN IGG SUBCLASS LIQUID REAGENT KITS FOR USE ON THE SPAPLUS ANALYSER
K070900 FREELITE HUMAN KAPPA AND LAMBDA FREE DIAGNOSTIC TEST KITS FOR USE ON THE ROCHE COBAS INTEGRA 400/400 PLUS ANALYZER KIT
K062372 FREELITE HUMAN KAPPA AND LAMBDA FREE KITS FOR USE ON THE SPAPLUS ANALYZER
Search all 115 clearances from The Binding Site, Ltd. →